Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonius A Miller

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|December 19, 2002
Body surface area in dosing anticancer agents: scratch the surface!Antonius A Miller
Lung Cancer (Amsterdam, Netherlands)|September 19, 2009
Using erlotinib to treat patients with non-small cell lung cancer who continue to smokeLynsay L Waller, Antonius A Miller, W Jeffrey Petty
Lung Cancer (Amsterdam, Netherlands)|October 20, 2006
Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancerAntonius A Miller, Amal Al Omari, Daryl J Murry, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004)Antonius A Miller, James E Herndon, Lin Gu, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Effects of continued tobacco use during treatment of lung cancerLynsay L Waller, Kathryn E Weaver, W Jeffrey Petty, et al.
Sarcoma|November 30, 2016
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic SarcomaPaul D Savage, James Lovato, K Bridget Brosnihan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancerAntonius A Miller, Doug Case, James N Atkins, et al.
The Oncologist|October 5, 2007
Small cell lung cancer: have we made any progress over the last 25 years?Brian E Lally, James J Urbanic, A William Blackstock, et al.
BMC Cancer|September 12, 2012
Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomasW Jeffrey Petty, Mebea Aklilu, Victor A Varela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Phase I study of lenalidomide in solid tumorsAntonius A Miller, Doug Case, Michele Harmon, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|December 19, 2002
Body surface area in dosing anticancer agents: scratch the surface!Antonius A Miller
Lung Cancer (Amsterdam, Netherlands)|September 19, 2009
Using erlotinib to treat patients with non-small cell lung cancer who continue to smokeLynsay L Waller, Antonius A Miller, W Jeffrey Petty
Lung Cancer (Amsterdam, Netherlands)|October 20, 2006
Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancerAntonius A Miller, Amal Al Omari, Daryl J Murry, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004)Antonius A Miller, James E Herndon, Lin Gu, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Effects of continued tobacco use during treatment of lung cancerLynsay L Waller, Kathryn E Weaver, W Jeffrey Petty, et al.
Sarcoma|November 30, 2016
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic SarcomaPaul D Savage, James Lovato, K Bridget Brosnihan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancerAntonius A Miller, Doug Case, James N Atkins, et al.
The Oncologist|October 5, 2007
Small cell lung cancer: have we made any progress over the last 25 years?Brian E Lally, James J Urbanic, A William Blackstock, et al.
BMC Cancer|September 12, 2012
Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomasW Jeffrey Petty, Mebea Aklilu, Victor A Varela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Phase I study of lenalidomide in solid tumorsAntonius A Miller, Doug Case, Michele Harmon, et al.
Pageof 5